Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | TT-00420 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TT-00420 | TT00420|TT 00420 | Aurka Inhibitors 24 Aurkb Inhibitors 20 | TT-00420 inhibits AURKA and AURKB, potentially resulting in decreased tumor growth (Cancer Res July 1 2018 (78) (13 Supplement) 5869). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03654547 | Phase I | TT-00420 | Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer | Recruiting | USA | 0 |